Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

Fig. 1

GlycA is greater in patients with mild–moderate RA compared with BMI-matched control subjects. Boxes represent the mean (middle horizontal line) and the 25th and 75th percentiles. Whiskers represent the 10th and 90th percentiles. Each data point is presented as an open circle. Mean ± standard deviation concentration of GlycA was greater in persons with RA (352.8 ± 67.2) than in controls (328.9 ± 53.5); P = 0.036 using an independent t test. RA rheumatoid arthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us